Dragičević, M.; Košuta, I.; Kruezi, E.; Lovrenčić, M.V.; Mrzljak, A.
Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease. Medicina 2020, 56, 622.
https://doi.org/10.3390/medicina56110622
AMA Style
Dragičević M, Košuta I, Kruezi E, Lovrenčić MV, Mrzljak A.
Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease. Medicina. 2020; 56(11):622.
https://doi.org/10.3390/medicina56110622
Chicago/Turabian Style
Dragičević, Maro, Iva Košuta, Egon Kruezi, Marijana Vučić Lovrenčić, and Anna Mrzljak.
2020. "Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease" Medicina 56, no. 11: 622.
https://doi.org/10.3390/medicina56110622
APA Style
Dragičević, M., Košuta, I., Kruezi, E., Lovrenčić, M. V., & Mrzljak, A.
(2020). Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease. Medicina, 56(11), 622.
https://doi.org/10.3390/medicina56110622